Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

C-reactive protein is neither a marker nor a mediator of atherosclerosis.

Pepys MB.

Nat Clin Pract Nephrol. 2008 May;4(5):234-5. doi: 10.1038/ncpneph0778. Epub 2008 Mar 4. Review. No abstract available.

PMID:
18317503
2.

The relationships between serum C-reactive protein level and risk and progression of coronary and carotid atherosclerosis.

Stone PA, Kazil J.

Semin Vasc Surg. 2014 Dec;27(3-4):138-42. doi: 10.1053/j.semvascsurg.2015.04.002. Epub 2015 Apr 6. Review.

PMID:
26073821
3.

Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression.

Siasos G, Tsigkou V, Oikonomou E, Zaromitidou M, Tsalamandris S, Mourouzis K, Vavuranakis M, Anastasiou M, Vlasis K, Limperi M, Gennimata V, Boletis JN, Papavassiliou AG, Tousoulis D.

Curr Med Chem. 2015;22(22):2619-35. Review.

PMID:
25876747
4.

Pulse pressure and inflammatory process in atherosclerosis.

Abramson JL, Vaccarino V.

Adv Cardiol. 2007;44:223-33. Review.

PMID:
17075211
5.

Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Shishehbor MH, Hazen SL.

Curr Atheroscler Rep. 2004 May;6(3):243-50. Review.

PMID:
15068750
6.

Inflammatory biomarkers in peripheral arterial disease.

Stone PA, Yacoub M.

Semin Vasc Surg. 2014 Dec;27(3-4):148-51. doi: 10.1053/j.semvascsurg.2015.01.009. Epub 2015 Jan 29. Review.

PMID:
26073823
7.

Proinflammatory status, genetics and atherosclerosis.

Poledne R, Lorenzová A, Stávek P, Valenta Z, Hubácek J, Suchánek P, Pitha J.

Physiol Res. 2009;58 Suppl 2:S111-8. Review.

8.

Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk.

Girndt M, Kohler H.

Nephrol Dial Transplant. 2003 Oct;18(10):1976-9. Review. No abstract available.

PMID:
13679468
9.

Inflammatory Biomarkers and Atherosclerosis.

Soeki T, Sata M.

Int Heart J. 2016;57(2):134-9. doi: 10.1536/ihj.15-346. Epub 2016 Mar 11. Review.

10.

[Role of C-reactive protein in atherogenesis].

Boncler M, Luzak B, Watala C.

Postepy Hig Med Dosw (Online). 2006;60:538-46. Review. Polish.

11.

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S.

Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Review.

12.

Cardiovascular risk factors, atherosclerosis and pulse pressure.

Amar J, Chamontin B.

Adv Cardiol. 2007;44:212-22. Review.

PMID:
17075210
13.

C-reactive protein incites atherosclerosis.

Verma S.

Can J Cardiol. 2004 Aug;20 Suppl B:29B-31B. Review.

PMID:
15309202
14.

C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.

Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R, Properzi G, Desideri G.

Curr Pharm Des. 2007;13(16):1631-45. Review.

PMID:
17584094
15.

High-Sensitivity C-Reactive Protein and Statin Initiation.

Trpkovic A, Stanimirovic J, Rizzo M, Resanovic I, Soskic S, Jevremovic D, Isenovic ER.

Angiology. 2015 Jul;66(6):503-7. doi: 10.1177/0003319714543000. Epub 2014 Jul 22. Review.

PMID:
25053677
16.

High-sensitivity C-reactive protein: clinical importance.

Bassuk SS, Rifai N, Ridker PM.

Curr Probl Cardiol. 2004 Aug;29(8):439-93. Review.

PMID:
15258556
17.

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Nordestgaard BG, Zacho J.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. doi: 10.1016/j.numecd.2009.07.005. Epub 2009 Aug 19. Review.

PMID:
19695857
18.

CRP and the risk of atherosclerotic events.

Calabrò P, Golia E, Yeh ET.

Semin Immunopathol. 2009 Jun;31(1):79-94. doi: 10.1007/s00281-009-0149-4. Epub 2009 May 5. Review.

PMID:
19415283
19.

Inflammatory markers and stroke.

Elkind MS.

Curr Cardiol Rep. 2009 Jan;11(1):12-20. Review.

PMID:
19091170
20.

[The role of inflammation factors in the development of atherosclerosis--clinical significance].

Mandecki T.

Pol Arch Med Wewn. 2001;105 Suppl:89-92. Review. Polish. No abstract available.

PMID:
12412229

Supplemental Content

Support Center